DK1212320T3 - Phenylpiperazinderivater som inhibitorer for genoptag af serotonin - Google Patents
Phenylpiperazinderivater som inhibitorer for genoptag af serotoninInfo
- Publication number
- DK1212320T3 DK1212320T3 DK00962355T DK00962355T DK1212320T3 DK 1212320 T3 DK1212320 T3 DK 1212320T3 DK 00962355 T DK00962355 T DK 00962355T DK 00962355 T DK00962355 T DK 00962355T DK 1212320 T3 DK1212320 T3 DK 1212320T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitors
- serotonin reuptake
- phenylpiperazine derivatives
- phenylpiperazine
- derivatives
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 title 1
- 230000000697 serotonin reuptake Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99202710 | 1999-08-23 | ||
| NL1012888 | 1999-08-23 | ||
| EP00962355A EP1212320B1 (fr) | 1999-08-23 | 2000-08-22 | Phenylpiperazines comme inhibiteurs de recapture de serotonine |
| PCT/EP2000/008190 WO2001014330A2 (fr) | 1999-08-23 | 2000-08-22 | Nouvelles phenylpiperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1212320T3 true DK1212320T3 (da) | 2005-08-08 |
Family
ID=26153354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00962355T DK1212320T3 (da) | 1999-08-23 | 2000-08-22 | Phenylpiperazinderivater som inhibitorer for genoptag af serotonin |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US7067513B1 (fr) |
| EP (1) | EP1212320B1 (fr) |
| JP (1) | JP4919565B2 (fr) |
| KR (1) | KR100634039B1 (fr) |
| CN (1) | CN1155596C (fr) |
| AR (1) | AR031526A1 (fr) |
| AT (1) | ATE299142T1 (fr) |
| AU (1) | AU772189B2 (fr) |
| BR (1) | BR0013498A (fr) |
| CA (1) | CA2379021C (fr) |
| CZ (1) | CZ298533B6 (fr) |
| DE (1) | DE60021194T2 (fr) |
| DK (1) | DK1212320T3 (fr) |
| ES (1) | ES2244469T3 (fr) |
| HU (1) | HUP0203194A3 (fr) |
| IL (2) | IL148218A0 (fr) |
| MX (1) | MXPA02001919A (fr) |
| NO (1) | NO321887B1 (fr) |
| NZ (1) | NZ517900A (fr) |
| PL (1) | PL201178B1 (fr) |
| PT (1) | PT1212320E (fr) |
| RU (1) | RU2246494C2 (fr) |
| SI (1) | SI1212320T1 (fr) |
| SK (1) | SK287018B6 (fr) |
| TR (1) | TR200200460T2 (fr) |
| TW (1) | TWI286136B (fr) |
| UA (1) | UA74160C2 (fr) |
| WO (1) | WO2001014330A2 (fr) |
| ZA (1) | ZA200201829B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067513B1 (en) | 1999-08-23 | 2006-06-27 | Solvay Pharmaceuticals B.V. | Phenylpiperazines |
| AR032711A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| US7041683B2 (en) | 2001-04-24 | 2006-05-09 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan |
| WO2002085896A1 (fr) * | 2001-04-24 | 2002-10-31 | Wyeth | Derives azaheterocyclylmethyle antidepresseurs de 2,3-dihydro-1,4-benzodioxane |
| US6656950B2 (en) * | 2001-04-25 | 2003-12-02 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4-dioxino[2,3-b]pyridine |
| WO2003007956A1 (fr) | 2001-07-20 | 2003-01-30 | Psychogenics, Inc. | Traitement des troubles de deficit de l'attention/hyperactivite |
| EP1336406A1 (fr) * | 2002-02-14 | 2003-08-20 | Solvay Pharmaceuticals B.V. | Agonistes partiels du récepteur D2 de la dopamine et inhibiteurs de la sérotonine et/ou de la noradrénaline |
| NZ536230A (en) * | 2002-05-13 | 2007-05-31 | Hoffmann La Roche | Benzoxazine derivatives as 5-hydroxytryptamine-6 (5-HT6) modulatory neurotransmitter in the brain |
| DE10233500A1 (de) * | 2002-07-24 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel |
| WO2004041792A1 (fr) | 2002-11-08 | 2004-05-21 | F. Hoffmann-La Roche Ag | Benzoxazinones substitues et utilisations associees |
| US7276603B2 (en) | 2003-05-02 | 2007-10-02 | Wyeth | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use |
| WO2004108671A1 (fr) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Indoles substitues dotes d'une affinite pour le recepteur de la serotonine, leur procede de fabrication et compositions pharmaceutiques les contenant |
| MX2007006758A (es) * | 2004-12-07 | 2007-11-09 | Solvay Pharm Bv | Derivados de benzdioxanpiperazina con una afinidad combinada para receptores de dopamina-d2 y sitios de reabsorcion de serotonina. |
| CA2587928A1 (fr) * | 2004-12-07 | 2006-06-15 | Solvay Pharmaceuticals B.V. | Phenylpiperazines comportant une combinaison de sites a affinite avec des recepteurs de dopamine d2 |
| US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
| US20060122247A1 (en) | 2004-12-08 | 2006-06-08 | Solvay Pharmaceuticals B.V. | Aryloxyethylamine and phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
| JP2008523031A (ja) * | 2004-12-08 | 2008-07-03 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | 部分的ドーパミン−d2受容体作動性とセロトニン再摂取阻害の組み合わせを示すフェニルピペラジン誘導体 |
| PE20070523A1 (es) | 2005-09-12 | 2007-06-28 | Wyeth Corp | Formulacion de liberacion sostenida del glucuronato de (8-{4-[3-(5-fluoro-1h-indol-3-il)-propil]-piperazin-1-il}-2-metil-4h-benzo[1,4]oxazin-3-ona |
| GT200600416A (es) * | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
| GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| FR2941946B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one-3-acetamidopiperazines substitues, leur preparation et leur application en therapeutique |
| AU2010266040B2 (en) * | 2009-06-25 | 2015-01-15 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds |
| EP3027607B1 (fr) | 2013-07-29 | 2020-08-26 | Sunshine Lake Pharma Co., Ltd. | Composés hétéroaryliques substitués et procédés d'utilisation |
| CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1075156A (en) | 1963-08-27 | 1967-07-12 | Luso Farmaco Inst | Substituted piperazines |
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| DE4127849A1 (de) | 1991-08-22 | 1993-02-25 | Merck Patent Gmbh | Benzodioxanderivate |
| US5314896A (en) | 1991-11-20 | 1994-05-24 | Warner-Lambert Company | 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| DE4333254A1 (de) | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| DE4414113A1 (de) | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
| US5576321A (en) | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
| AR004229A1 (es) | 1995-11-06 | 1998-11-04 | Wyeth Corp | Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos |
| ZA9711376B (en) | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
| DE19730989A1 (de) | 1997-07-18 | 1999-01-21 | Merck Patent Gmbh | Piperazin-Derivate |
| EP1007523B9 (fr) * | 1997-07-25 | 2004-09-08 | H. Lundbeck A/S | Derives indole et 2,3-dihydro-indole, leur preparation et utilisation |
| DE69819266T2 (de) * | 1997-09-02 | 2004-07-29 | Duphar International Research B.V. | Piperidin- und Piperazin Derivate als 5-HT1-Rezeptor-Agonisten |
| EP0900792B1 (fr) | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Dérivés de pipéridine et de pipérazine comme agonistes du récepteur 5-HT1 |
| SK19412000A3 (sk) * | 1998-06-19 | 2001-07-10 | H. Lundbeck A/S | Substituované 4,5,6 a 7-indolové alebo indolínové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
| EP1089997A1 (fr) * | 1998-06-19 | 2001-04-11 | H.Lundbeck A/S | Derives de 4, 5, 6, et 7-indole ou d'indoline, leur preparation, et leur utilisation |
| AR020773A1 (es) | 1998-10-16 | 2002-05-29 | Duphar Int Res | Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto |
| AR022303A1 (es) * | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion |
| US7067513B1 (en) | 1999-08-23 | 2006-06-27 | Solvay Pharmaceuticals B.V. | Phenylpiperazines |
| AR032712A1 (es) * | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
| AR032711A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene |
| EP1336406A1 (fr) | 2002-02-14 | 2003-08-20 | Solvay Pharmaceuticals B.V. | Agonistes partiels du récepteur D2 de la dopamine et inhibiteurs de la sérotonine et/ou de la noradrénaline |
-
2000
- 2000-08-22 US US10/069,256 patent/US7067513B1/en not_active Expired - Fee Related
- 2000-08-22 PL PL364821A patent/PL201178B1/pl not_active IP Right Cessation
- 2000-08-22 KR KR1020027002242A patent/KR100634039B1/ko not_active Expired - Fee Related
- 2000-08-22 PT PT00962355T patent/PT1212320E/pt unknown
- 2000-08-22 WO PCT/EP2000/008190 patent/WO2001014330A2/fr not_active Ceased
- 2000-08-22 CZ CZ20020619A patent/CZ298533B6/cs not_active IP Right Cessation
- 2000-08-22 HU HU0203194A patent/HUP0203194A3/hu unknown
- 2000-08-22 SK SK249-2002A patent/SK287018B6/sk not_active IP Right Cessation
- 2000-08-22 AT AT00962355T patent/ATE299142T1/de active
- 2000-08-22 AR ARP000104326A patent/AR031526A1/es active IP Right Grant
- 2000-08-22 NZ NZ517900A patent/NZ517900A/en not_active IP Right Cessation
- 2000-08-22 TR TR2002/00460T patent/TR200200460T2/xx unknown
- 2000-08-22 BR BR0013498-8A patent/BR0013498A/pt active Search and Examination
- 2000-08-22 UA UA2002032313A patent/UA74160C2/uk unknown
- 2000-08-22 DE DE60021194T patent/DE60021194T2/de not_active Expired - Lifetime
- 2000-08-22 JP JP2001518420A patent/JP4919565B2/ja not_active Expired - Fee Related
- 2000-08-22 SI SI200030720T patent/SI1212320T1/xx unknown
- 2000-08-22 CN CNB008118655A patent/CN1155596C/zh not_active Expired - Fee Related
- 2000-08-22 DK DK00962355T patent/DK1212320T3/da active
- 2000-08-22 EP EP00962355A patent/EP1212320B1/fr not_active Expired - Lifetime
- 2000-08-22 ES ES00962355T patent/ES2244469T3/es not_active Expired - Lifetime
- 2000-08-22 AU AU74118/00A patent/AU772189B2/en not_active Ceased
- 2000-08-22 RU RU2002107318/04A patent/RU2246494C2/ru not_active IP Right Cessation
- 2000-08-22 MX MXPA02001919A patent/MXPA02001919A/es active IP Right Grant
- 2000-08-22 CA CA002379021A patent/CA2379021C/fr not_active Expired - Fee Related
- 2000-08-22 IL IL14821800A patent/IL148218A0/xx active IP Right Grant
- 2000-09-01 TW TW089117890A patent/TWI286136B/zh not_active IP Right Cessation
-
2002
- 2002-02-18 IL IL148218A patent/IL148218A/en not_active IP Right Cessation
- 2002-02-19 NO NO20020810A patent/NO321887B1/no not_active IP Right Cessation
- 2002-03-05 ZA ZA200201829A patent/ZA200201829B/xx unknown
-
2006
- 2006-06-12 US US11/450,323 patent/US7456182B2/en not_active Expired - Fee Related
-
2008
- 2008-10-27 US US12/258,591 patent/US7605162B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1212320T3 (da) | Phenylpiperazinderivater som inhibitorer for genoptag af serotonin | |
| DK1436271T3 (da) | Phenylpiperazinderivater som serotonin-genoptagelseshæmmere | |
| NO20034307L (no) | Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer | |
| NO20021659D0 (no) | Biaryleterderivater nyttige som monoamin reopptaksinhibitorer | |
| DK1460066T3 (da) | Piperazinforbindelse som tachykinin-inhibitorer | |
| NO20021239D0 (no) | Pteridinoner som kinase-inhibitorer | |
| NO20014483L (no) | Aminderivater som proteaseinhibitorer | |
| NO20030842L (no) | Fenoksybenzylaminderivater som selektive serotonin- gjenopptaksinhibitorer | |
| NO20021459D0 (no) | Piperazin-derivater som 5-HT1B-antagonister | |
| DK1438289T3 (da) | Indolderivater som cox II-inhibitorer | |
| NO20034525D0 (no) | Fenyl heterocyklyleterderivater som serotonin re- opptaksinhibitorer | |
| NO20023001D0 (no) | Substituerte piperazinderivater som MTP inhibitorer | |
| NO20022123D0 (no) | Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII | |
| NO20015033D0 (no) | Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner | |
| DK1682523T3 (da) | Morpholin-derivater som noradrenalin-genoptagelsesinhibitorer | |
| DK1146041T3 (da) | Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin | |
| DK1860100T3 (da) | 2-(1H-indolylsulfanyl)-benzylaminderivater som SSRI | |
| DK1377550T3 (da) | Phenyl-heterocyclyletherderivater som serotonin-re-uptakeinhibitorer |